References
- Cohn Jay B. Multicentre double blind efficacy and safety study comparing alprazolam, diazepam and placebo in clinically anxious patients. Journal of Clinical Psychiatry 1981; 42: 347–351
- Feighner J. P., Aden G. C., Fabre L. F., Rickels K, Smith W. J. Comparison of alprazolam, diazepam and placebo in the treatment of depression. J.A.M.A. 1983; Vol. 249(22)3057–3064, June 10
- Davidson K., Farquaarson R. G., Khan M. C., Majid A. A double blind comparison of alprazolam, diazepam, and placebo in the treatment of anxious outpatients. Psychopharmacology 1983; 80: 308–310
- Maletzky B. M. Anxiolytic effect of alprazolam compared to diazepam and placebo. Journal of International Medical Research 1980; 8: 139–143
- Molnar E., Evans L. The management of phobias. Patient Management 1983, Feb. 23–25
- Sheehan D. B. Current perspectives in the treatment of panic and phobic disorder. Drug Therapy 1982; 179–189, September
- Bennaheim D A., Messner R P. Recent observations on central nervous system lupus erythematosus. Seminars in Arthritis and Rheumatism 1975; 4: 253–266
- Feinglass E J., Arnett F C., Dorsch C A., et al. Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease. Medicine (Baltimore) 1976; 55: 323–339
- Lee P, Urowitz M B., Koehler B E., et al. Systemic lupus erythematosus. A review of 110 cases with reference to nephritis. Quarterly Journal of Medicine 1977; 46: 1–32
- Hughes Grv. Systemic lupus erythematosus: treatment and prognosis. British Medical Journal 1979; 1919–1922
- Liang M H., Meenan R F., Cathcart E S., et al. A screening strategy for population studies in systemic lupus erythematosus. Arthritis and Rheumatism 1980; 23: 153–157
- Tan E M., Cohen A S., Fries J F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis and Rheumatism 1982; 25: 1271–1277
- Winfield J B., Brunner C M., Koffler D. Serologic studies in patients with systemic lupus erythematosus and central nervous system dysfunction. Arthritis and Rheumatism 1978; 21: 289–294
- Winn D M., Wolfe J F., Lindberg D A., et al. Identification of a clinical subset of systemic lupus erythematosus by antibodies to the SM antigen. Arthritis and Rheumatism 1979; 22: 1334–1337
- Bluestein H G., Zvaifler N J. Brain-reactive lymphocytotoxic antibodies in the serum of patients with systemic lupus erythematosus. Journal of Clinical Investigation 1976; 57: 509–516
- Bresnihan B, Oliver M, Williams B, et al. An antineuronal antibody cross-reacting with erythrocytes and lymphocytes in systemic lupus erythematosus. Arthritis and Rheumatism 1979; 22: 313–320
- Miniter M F., Stollar B D., Agnello V. Reassessment of the clinical significance of native DNA antibodies in systemic lupus erythematosus. Arthritis and Rheumatism 1979; 22: 959–968
- Johnstone E C., Whaley K. Antinuclear antibodies in psychiatric illness: their relationship to diagnosis and drug treatment. British Medical Journal 1975; 2: 724–725